A meta-analysis showed the low sensitivity and specificity of 18F-FDG PET/CT in predicting the KRAS mutation in CRC [20], and more recently Taguchi et al. found an association between two CT-TA parameters (skewness and max value) and the KRAS mutational status [21]. The gene discussed is KRAS; the disease is colorectal carcinoma.